Google is rolling out Gemini to smartwatches running Wear OS 4 or later, including devices from Pixel, Samsung, OPPO, OnePlus, and Xiaomi. Users can launch the AI assistant with a voice command, side button, or app icon to get answers right on their wrist - from checking the weather and calendar appointments to reading emails. If permissions are granted, Gemini pulls information from Google services like Gmail, Calendar, and Maps. Voice controls also let users manage reminders and messages.
The feature will be available globally over the next few weeks, with partial support for manufacturer-specific apps coming later with Wear OS 6.
Anthropic is rolling out new integrations for its Claude AI chatbot, connecting it with the Canvas learning platform, Panopto, and Wiley. Students can access lecture recordings, academic literature, and other course materials directly in Claude. Wiley supplies scientific resources, while Panopto provides lecture transcripts. The integration uses Anthropic's own Model Context Protocol (MCP), and the connection with Canvas is based on the Learning Tools Interoperability (LTI) standard.
Anthropic says all conversations are private by default and aren't used for training. Partners include the University of San Francisco School of Law and Northumbria University.
Perplexity has introduced "Comet," an AI-powered browser designed to replace traditional tabs with an interface that uses LLMs to help users navigate the web. With Comet, users can write emails, plan meetings, compare products, ask questions, or highlight text to get instant explanations. Perplexity says the goal is to make browsing simpler and give people better access to information. Comet will launch first for Perplexity Max subscribers at $200 per month, with access managed through a waitlist and invitation system starting this summer.
OpenAI and the American Federation of Teachers (AFT) are launching the National Academy for AI Instruction, a five-year initiative aimed at training 400,000 teachers across the United States to use artificial intelligence in the classroom. OpenAI is contributing $10 million to the effort, with $8 million in direct funding and $2 million in technical support. The goal is to help teachers integrate AI into their teaching, with a special focus on underserved school districts.
The project is backed by additional partners, including Microsoft, Anthropic, and the United Federation of Teachers. The first training center is being built in New York City, with plans to open more by 2030. Teachers will have access to workshops, online courses, and hands-on training, along with priority access to OpenAI tools, technical support, and resources to build their own AI-powered classroom applications.
CoreWeave is set to acquire data center provider Core Scientific in a share swap deal worth about $9 billion. The transaction is expected to close in the fourth quarter of 2025. Core Scientific adds 1.3 gigawatts of existing power capacity, plus more than 1 gigawatt of expansion potential.
Capgemini is investing $3.3 billion to bring generative AI and so-called "agentic AI" into its clients' business operations.
The company plans to acquire WNS, a provider of digital business process services, as part of this push. "Business Process Services will be the showcase for Agentic AI," Capgemini CEO Aiman Ezzat said about the deal. WNS already delivers AI-powered process solutions to companies in eight industries, counting United Airlines and Aviva among its clients.
Capgemini and WNS say the goal is to become a leader in intelligent operations by using autonomous AI to fundamentally rethink how businesses run their core processes.
Isomorphic Labs, a Deepmind spin-off focused on drug discovery, is getting ready for its first clinical trials with drugs designed using AlphaFold-based AI models.
"We're staffing up now. We're getting very close," said Colin Murdoch, President of Isomorphic Labs and Chief Business Officer at Deepmind, in an interview with Fortune.
The company wants to overhaul the traditionally slow and expensive process of drug development, with anti-cancer drugs already in the pipeline. Isomorphic Labs has signed agreements with Eli Lilly and Novartis, and in 2025 closed a USD 600 million investment roundled by Thrive Capital.
Looking ahead, Isomorphic Labs has even bigger ambitions for AI in medicine. "One day we hope to be able to say— well, here's a disease, and then click a button and out pops the design for a drug to address that disease," Murdoch said.
